Roger Sawhney

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Tuan Nguyen as attorney-in-fact for Roger Sawhney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Roger Sawhney

Form 4 holding Chief Financial Officer

Omega Therapeutics, Inc.

Security class
Option (Right to Buy)
Shares / value
60,000
Estimated value
Report date
09 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ACTUATE THERAPEUTICS, INC.

Security class
Non-Qualified Stock Options
Shares / value
30,000
Estimated value
Report date
12 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Adlai Nortye Ltd.

Security class
American Depositary Shares
Shares / value
9,838
Estimated value
Report date
18 Mar 2026
Price
Ownership
Direct
Form 4 holding Director

ALIMERA SCIENCES INC

Security class
Stock Option (Right to Buy)
Shares / value
2,252
Estimated value
Report date
25 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Roger Sawhney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .